2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Urogenital Neoplasms
1
Ovarian Neoplasms
1
Ovarian Diseases
1
Ovarian Cysts
1
Neoplasms
1
Gonadal Disorders
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Endocrine System Diseases
1
Endocrine Gland Neoplasms
1
Disease
1
Cysts
1
Adnexal Diseases
1
Interventions
Carboplatin
3
Bevacizumab
3
olaparib
2
niraparib
2
anlotinib
2
Paclitaxel
2
Diet, Mediterranean
2
Blood Specimen Collection
2
temsirolimus
1
relacorilant
1
pembrolizumab
1
nintedanib
1
liposomal doxorubicin
1
lenvatinib
1
entinostat
1
avelumab
1
Trabectedin
1
Tissue Banks
1
Papanicolaou Test
1
Ocoxin
1
NUC-1031
1
Gemcitabine
1
Food, Formulated
1
Filgrastim
1
Diffusion
1
Dexamethasone
1
Cell Count
1
CP protocol
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Diseases
×
Diffusion
×
Clear all
NCT02836275
2020-04-14
IOTA-MRI
KU Leuven
Phase NA
Unknown
250 enrolled